No products in the cart.
LD TECHNOLOGY
TM FLOW INTENDED USE:
TM FLOW INTENDED USE:
- Measurement of Ankle Brachial Indices for the screening of Peripheral Artery Disease.
- Measurement of Ankle Brachial Indices for the screening of Peripheral Artery Disease.
- Measurement of the Galvanic Skin response related to the sudomotor function.
-
Mathematical Analysis of the Photoplethysmography for assessing:
- The autonomic nervous system via Heart Rate Variability Analysis at rest and during the Ewing Tests.
- The Endothelial function via the Photoplethysmography (PTG) Analysis.
Play Video
TM-FLOW ASSESMENTS
BLOOD PRESSURE AND ARTERIAL STIFFNESS ANALYSIS
Monitoring and treatment.
Management of hypertension
PHOTOPLETHYSMOGRAPHY
Mathematical Analysis of the pulse Ox wave
ANKLE BRAKIAL INDEX (ABI)
Peripheral Artery Disease (PAD). Blood flow blockage or calcification
HEART RATE VARIABILITY (HRV)
Cardiac Autonomic Dysfunction Assessment
CARDIAC AUTOMATIC REFLEX TESTs (CARTs)
Cardiac Autonomic Neuropathy assessment
SUDOMOTOR FUNCTION TESTS
Skin Microcirculation and small fiber Assessments
TM-FLOW ASSESMENTS
MAIN SYMPTOMS OF AUTONOMIC NEUROPATHY AND VASCULAR DYSFUNCTION
MAIN SYMPTOMS OF AUTONOMIC NEUROPATHY AND VASCULAR DYSFUNCTION
- FATIGUE
- HEADACHE
- DIZZINESS
- EXERCISE INTOLERANCE
- PAINFUL MUSCLE CRAMPING
- FAINTING
- TINGLING IN THE TOES OR FINGERS
- CLAUDICATION
- THIGHS OR CALVES WHEN WALKING
- CLIMBING STAIRS OR EXERCING
USA POPULATION THAT SHOULD BE TESTED BY LD TECHNOLOGY PRODUCTS
50+
Population over 50 years old
with cardiovascular risk factors
(Hypertensive, Overweight, Smoker, Diabetic)
70+
Population over 70 years old.
USA POPULATION THAT SHOULD BE TESTED BY LD TECHNOLOGY PRODUCTS
USA POPULATION THAT SHOULD BE TESTED BY LD TECHNOLOGY PRODUCTS
50+
Population over 50 years old
with cardiovascular risk factors
(Hypertensive, Overweight, Smoker, Diabetic)
70+
Population over 70 years old.
EVERYONE IN THE RISK GROUP SHOULD BE MEASURED WITH TM-FLOW SYSTEM.
EVERYONE IN THE RISK GROUP SHOULD BE MEASURED WITH
TM-FLOW SYSTEM.
MAIN MARKERS
VASCULAR FUNCTION ASSESSMENT
VASCULAR FUNCTION ASSESSMENT
- Arterial stiffness and Ankle Brachial Indices from the Volume plethysmography analysis.
- Endothelial FunctionPatented markers from mathematical analysis of the photoplethysmography spectral analysis. (Off label use).
AUTONOMIC NERVOUS SYSTEM ASSESSMENT
AUTONOMIC NERVOUS SYSTEM ASSESSMENT
- Sudomotor Function Markers.
- Heart rate variability Analysis (HRV).
- Cardiac Autonomic Reflex Tests: - Valsalva Ratio, - E/I Ratio , - K30/15 Ratio and - Systolic Pressure Response to Standing.
CLINICAL VALIDATION
-
PTG Spectral Analysis Markers to:
- The gold standard of Insulin resistance assessment.
- The Coronary angiography.
- Vascular blood tests (CRP and fibrinogen). -
Sudomotor markers to the:
- Small fiber Neuropathy Symptoms.
- Microvascular disease (retinopathy).
- Cardiometabolic Score to the Oral Glucose Tolerance Test (OGTT).
See results in page Clinical Studies
TM FLOW HARDWARE COMPONENTS
This video animation shows you the full components of the TM FLOW system.
It will help the user to properly setup the hardware and how to charge the wireless devices.
PATIENT SETUP
